Open access · CC-BY
via OpenAlex
Nanocarriers for natural polyphenol senotherapeutics
Natali Joma, Patrick‐Brian Bielawski, Anjali Saini, Ashok K. Kakkar, Dušica Maysinger
Aging Cell · 2024 · ▲ 33 citations
Cellular senescence
Altered intercellular communication
Senolytics
Human
Preclinical / animal
Review
Abstract
Senescence(definition) is a heterogenous and dynamic process in which various cell types undergo cell-cycle arrest due to cellular stressors. While senescence has been implicated in aging and many human pathologies, therapeutic interventions remain inadequate due to the absence of a comprehensive set of biomarkers in a context-dependent manner. Polyphenols have been investigated as senotherapeutics in both preclinical and clinical settings. However, their use is hindered by limited stability, toxicity, modest bioavailability, and often inadequate concentration at target sites. To address these limitations, nanocarriers such as polymer nanoparticles and lipid vesicles can be utilized to enhance the efficacy of senolytic polyphenols. Focusing on widely studied senolytic agents-specifically fisetin, quercetin, and resveratrol-we provide concise summaries of their physical and chemical properties, along with an overview of preclinical and clinical findings. We also highlight common signaling pathways and potential toxicities associated with these agents. Addressing challenges linked to nanocarriers, we present examples of senotherapeutic delivery to various cell types, both with and without nanocarriers. Finally, continued research and development of senolytic agents and nanocarriers are encouraged to reduce the undesirable effects of senescence on different cell types and organs. This review underscores the need for establishing reliable sets of senescence biomarkers that could assist in evaluating the effectiveness of current and future senotherapeutic candidates and nanocarriers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.14178
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Joma, N., Bielawski, P., Saini, A., Kakkar, A.K., & Maysinger, D. (2024). Nanocarriers for natural polyphenol senotherapeutics. <em>Aging Cell</em>. https://doi.org/10.1111/acel.14178
Vancouver
Joma N, Bielawski P, Saini A, Kakkar AK, Maysinger D. Nanocarriers for natural polyphenol senotherapeutics. Aging Cell. 2024. doi:10.1111/acel.14178.
BibTeX
@article{natali2024Nanoca,
title = {Nanocarriers for natural polyphenol senotherapeutics},
author = {Natali Joma and Patrick‐Brian Bielawski and Anjali Saini and Ashok K. Kakkar and Dušica Maysinger},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14178},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Central Asian Journal of Medical Hypotheses and Ethics 2025
Open access · CC-BY
SENOLYTICS AND SENOMORPHICS: A NEW CLASS OF DRUGS FOR ANTI-AGING THERAPY
Biogerontology 2026
Citation only
Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.
Cancer Management and Research 2020
Open access · OA
The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
EBioMedicine 2023
Open access · CC-BY
Cellular senescence in asthma: from pathogenesis to therapeutic challenges
Aging Cell 2023
Open access · CC-BY
Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents
Frontiers in Immunology 2020
Open access · CC-BY